期刊论文详细信息
Health Research Policy and Systems
The financial burden from non-communicable diseases in low- and middle-income countries: a literature review
David B Evans1  Ke Xu3  Priyanka Saksena1  Hyacinthe Tchewonpi Kankeu2 
[1] Department of Health Systems Financing, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland;Aix-Marseille University (Aix-Marseille School of Economics), CNRS & EHESS, Centre de la Vieille Charité, 2 Rue de la Charité, 13236 Marseille, Cedex 2, France;WHO Regional Office for the Western Pacific Region, P.O. Box 2932, 1000 Manila, Philippines
关键词: Review;    Non-communicable diseases;    Low- and middle-income countries;    Financial burden;   
Others  :  809686
DOI  :  10.1186/1478-4505-11-31
 received in 2013-03-26, accepted in 2013-07-18,  发布年份 2013
PDF
【 摘 要 】

Non-communicable diseases (NCDs) were previously considered to only affect high-income countries. However, they now account for a very large burden in terms of both mortality and morbidity in low- and middle-income countries (LMICs), although little is known about the impact these diseases have on households in these countries. In this paper, we present a literature review on the costs imposed by NCDs on households in LMICs. We examine both the costs of obtaining medical care and the costs associated with being unable to work, while discussing the methodological issues of particular studies. The results suggest that NCDs pose a heavy financial burden on many affected households; poor households are the most financially affected when they seek care. Medicines are usually the largest component of costs and the use of originator brand medicines leads to higher than necessary expenses. In particular, in the treatment of diabetes, insulin – when required – represents an important source of spending for patients and their families. These financial costs deter many people suffering from NCDs from seeking the care they need. The limited health insurance coverage for NCDs is reflected in the low proportions of patients claiming reimbursement and the low reimbursement rates in existing insurance schemes. The costs associated with lost income-earning opportunities are also significant for many households. Therefore, NCDs impose a substantial financial burden on many households, including the poor in low-income countries. The financial costs of obtaining care also impose insurmountable barriers to access for some people, which illustrates the urgency of improving financial risk protection in health in LMIC settings and ensuring that NCDs are taken into account in these systems. In this paper, we identify areas where further research is needed to have a better view of the costs incurred by households because of NCDs; namely, the extension of the geographical scope, the inclusion of certain diseases hitherto little studied, the introduction of a time dimension, and more comparisons with acute illnesses.

【 授权许可】

   
2013 Kankeu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140709020843303.pdf 310KB PDF download
Figure 1. 52KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]World Health Organization: Global Status Report on Non-communicable Diseases 2010. Geneva: World Health Organization; 2011.
  • [2]United Nations: Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York: United Nations: 66th session of the General Assembly, High-level Meeting on the Prevention and Control of Non-communicable Diseases; 2011.
  • [3]Lin J-M, Resch SC, Brimmer DJ, Johnson A, Kennedy S, Burstein N, Simon CJ: The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Eff Resour Alloc 2011, 9:1. BioMed Central Full Text
  • [4]Schofield D, Passey M, Percival R, Shrestha R, Callander E, Kelly S: Retiring early with cardiovascular disease - impact on individual’s financial assets. Int J Cardiol 2010, 92:125-126.
  • [5]Pollack CE, Griffin BA, Lynch J: Housing affordability and health among homeowners and renters. Am J Prev Med 2010, 39:515-521.
  • [6]Barrett AM, Colosia AD, Boye KS, Oyelowo O: Burden of Obesity: 10-year Review of the Literature on Costs in Nine Countries. Toronto, Canada: ISPOR 13th Annual International Meeting; 2008.
  • [7]Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA: Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 2004, 7:186-194.
  • [8]Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fatima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein A, Weinstein C: The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum; 2011.
  • [9]World Health Organization: World Health Statistics 2012. Geneva: World Health Organization; 2012.
  • [10]McIntyre D, Thiede M, Dahlgren G, Whitehead M: What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med 2006, 62:858-865.
  • [11]World Bank: World Bank GNI per capita Operational Guidelines & Analytical Classifications. Washington, DC: World Bank; 2011.
  • [12]World Health Organization: Preventing Chronic Diseases: A Vital Investment: WHO Global Report. Geneva: World Health Organization; 2005.
  • [13]Engelgau M, Rosenhouse S, El-Saharty S, Mahal A: The economic effect of noncommunicable diseases on households and nations: a review of existing evidence. J Health Commun 2011, 16:75-81.
  • [14]Ir P, Men C, Lucas H, Meessen B, Decoster K, Bloom G, Van Damme W: Self-reported serious illnesses in rural Cambodia: a cross-sectional survey. PLoS One 2010, 5:e10930.
  • [15]Shi W, Chongsuvivatwong V, Geater A, Zhang J, Zhang H, Brombal D: The influence of the rural health security schemes on health utilization and household impoverishment in rural China: data from a household survey of western and central China. Int J Equity Health 2010, 9:7. BioMed Central Full Text
  • [16]Sun Q, Liu X, Meng Q, Tang S, Yu B, Tolhurst R: Evaluating the financial protection of patients with chronic disease by health insurance in rural China. Int J Equity Health 2009, 8:42. BioMed Central Full Text
  • [17]Gotsadze G, Zoidze A, Rukhadze N: Household catastrophic health expenditure: evidence from Georgia and its policy implications. BMC Health Serv Res 2009, 9:69. BioMed Central Full Text
  • [18]Ruhweza M, Baine SO, Onama V, Pariyo G: Financial risks associated with healthcare consumption in Jinja, Uganda. Afr Health Sci 2009, 9:S86-S89.
  • [19]Abegunde DO, Stanciole AE: The economic impact of chronic diseases: how do households respond to shocks? Evidence from Russia. Soc Sci Med 2008, 66:2296-2307.
  • [20]Thuan NTB, Lofgren C, Chuc NTK, Janlert U, Lindholm L: Household out-of-pocket payments for illness: evidence from Vietnam. BMC Publ Health 2006, 6:283. BioMed Central Full Text
  • [21]Gotsadze G, Bennett S, Ranson K, Gzirishvili D: Health care-seeking behaviour and out-of-pocket payments in Tbilisi, Georgia. Health Policy Plan 2005, 20:232-242.
  • [22]Sari N, Langenbrunner JC: Consumer out-of-pocket spending for pharmaceuticals in Kazakhstan: implications for sectoral reform. Health Policy Plan 2001, 16:428-434.
  • [23]Grover S, Avasthi A, Bhansali A, Chakrabarti S, Kulhara P: Cost of ambulatory care of diabetes mellitus: a study from north India. Postgrad Med J 2005, 81:391-395.
  • [24]Gombet TR, Ellenga-Mbolla BF, Ikama MS, Ekoba J, Kimbally-Kaky G: Cost of emergency cardiovascular care at the University Hospital Center in Brazzaville, Congo. Med Trop 2009, 69:45-47.
  • [25]Pepper DJ, Levitt NS, Cleary S, Burch VC: Hyperglycaemic emergency admissions to a secondary-level hospital – an unnecessary financial burden. S Afr Med J 2007, 97:963-967.
  • [26]Atipo-Ibara BI, Ondele-Ngoli A, Deby-Gassaye , Ibara JR, Okouo M, Ngoma-Kadoulou P, Itoua-Ngaporo A: Cost of hospital management of cirrhoses and its complications at the University Hospital of Brazzaville. Med Trop 2004, 64:50-52.
  • [27]Obi SN, Ozumba BC: Cervical cancer: socioeconomic implications of management in a developing nation. J Obstet Gynaecol 2008, 28:526-528.
  • [28]Arrossi S, Matos E, Zengarini N, Roth B, Sankaranayananan R, Parkin M: The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study. Gynecol Oncol 2007, 105:335-340.
  • [29]Ross H, Trung DV, Phu VX: The costs of smoking in Vietnam: the case of inpatient care. Tob Control 2007, 16:405-509.
  • [30]Thomas SV, Sarma PS, Alexander M, Pandit L, Shekhar L, Trivedi C, Vengamma B: Economic burden of epilepsy in India. Epilepsia 2001, 42:1052-1060.
  • [31]Zhou B, Yang L, Sun Q, Gu H, Wang B: Social health insurance and drug spending among cancer inpatients in China. Health Affair (Millwood) 2008, 27:1020-1027.
  • [32]De-Graft Aikins A: Healer shopping in Africa: new evidence from rural–urban qualitative study of Ghanaian diabetes experiences. BMJ 2005, 331:737.
  • [33]González-González C, Sanchez-Garcia S, Juarez-Cedillo T, Rosas-Carrasco O, Gutiérrez-Robledo LM, Garcia-Peña C: Health care utilization in the elderly Mexican population: expenditures and determinants. BMC Publ Health 2011, 11:192. BioMed Central Full Text
  • [34]Goldhaber-Fiebert JD, Li H, Ratanawijitrasin S, Vidyasagar S, Wang XY, Aljunid S, Shah N, Wang Z, Hirunrassamee S, Bairy KL, Wang J, Saperi S, Nur AM, Eggleston K: Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia. Diabet Med 2010, 27:101-108.
  • [35]Heeley E, Anderson CS, Huang Y, Jan S, Li Y, Liu M, Sun J, Xu E, Wu Y, Yang Q, Zhang J, Zhang S, Wang J: Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke 2009, 40:2149-2156.
  • [36]Shobhana R, Rama Rao P, Lavanya A, Williams R, Vijay V, Ramachandran A: Expenditure on health care incurred by diabetic subjects in a developing country: a study from southern India. Diabetes Res Clin Pract 2000, 48:37-42.
  • [37]Goudge J, Gilson L, Russell S, Gumede T, Mills A: Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv Res 2009, 9:75. BioMed Central Full Text
  • [38]Chuma J, Gilson L, Molyneux C: Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban households in Coastal Kenya: an equity analysis. Trop Med Int Health 2007, 12:673-686.
  • [39]Russell S, Gilson L: Are health services protecting the livelihoods the urban poor in Sri Lanka? Findings from two low-income areas of Colombo. Soc Sci Med 2006, 63:1732-1744.
  • [40]Mondal S, Kanjilal B, Peters DH, Lucas H: Catastrophic Out-of-pocket Payment for Health Care and its Impact on Households: Experience from West Bengal, India. Baltimore, MD: Future Health Systems; 2010.
  • [41]Niëns LM, Cameron A, Van De Poel E, Ewen M, Brouwer WBF, Laing R: Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med 2010, 7(8):e1000333.
  • [42]Yip W, Hsiao WC: Non-evidence-based policy: how effective is China’s new cooperative medical scheme in reducing medical impoverishment? Soc Sci Med 2009, 68:201-209.
  • [43]Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL: Household catastrophic health expenditure: a multicountry analysis. Lancet 2003, 362:111-117.
  • [44]Mukherjee S, Haddad S, Narayana D: Social class related inequalities in household health expenditure and economic burden: evidence from Kerala, south India. Int J Equity Health 2011, 10:1-13. BioMed Central Full Text
  • [45]Ramachandran A, Ramachandran S, Snehalatha C, Augustine C, Murugesan N, Viswanathan V, Kapur A, Williams R: Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India. Diabetes Care 2007, 30:252-256.
  • [46]Elrayah H, Eltom M, Bedri A, Belal A, Rosling H, Östenson C-G: Economic burden on families of childhood type 1 diabetes in urban Sudan. Diabetes Res Clin Pract 2005, 70:159-165.
  • [47]Falconer DG, Buckley A, Colagiuri R: Counting the cost of type 2 diabetes in Vanuatu. Diabetes Res Clin Pract 2010, 87:92-97.
  • [48]Rayappa PH, Raju KNM, Kapur A, Bjork S, Sylvest C, Kumar KMD: Economic cost of diabetes care: the Bangalore urban district diabetes study. Int J Diabetes Dev C 1999, 19:87-97.
  • [49]Villarreal-Ríos E, Salinas-Martínez AM, Medina-Jáuregui A, Garza-Elizondo ME, Núñez-Rocha G, Chuy-Díaz ER: The cost of diabetes mellitus and its impact on health spending in Mexico. Arch Med Res 2000, 31:511-514.
  • [50]Khowaja LA, Khuwaja AK, Cosgrove P: Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC Health Serv Res 2007, 7:189. BioMed Central Full Text
  • [51]Kapur A: Economic analysis of diabetes care. Indian J Med Res 2007, 125:473-482.
  • [52]Rao KD, Bhatnagar A, Murphy A: Socio-economic inequalities in the financing of cardiovascular & diabetes inpatient treatment in India. Indian J Med Res 2011, 133:57-63.
  • [53]Mahmood N, Ali Mubashir S: The disease pattern and utilisation of health care services in Pakistan. Pakistan Devel Rev 2002, 41:745-757.
  • [54]Patankar AM, Trivedi PL: Monetary burden of health impacts of air pollution in Mumbai, India: implications for public health policy. Public Health 2011, 125:157-164.
  • [55]Dror DM, van Putten-Rademaker O, Koren R: Cost of illness: evidence from a study in five resource-poor locations in India. Indian J Med Res 2008, 127:347-361.
  • [56]Su TT, Kouyaté B, Flessa S: Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bull World Health Organ 2006, 84:21-27.
  • [57]Salti N, Chaaban J, Raad F: Health equity in Lebanon: a microeconomic analysis. Int J Equity Health 2010, 9:11. BioMed Central Full Text
  • [58]Hao Y, Wu Q, Zhang Z, Gao L, Ning N, Jiao M, Zakus D: The impact of different benefit packages of Medical Financial Assistance Scheme on health service utilization of poor population in rural China. BMC Health Serv Res 2010, 10:170. BioMed Central Full Text
  • [59]World Health Organization: WHO Guide to Identifying the Economic Consequences of Disease and Injury. Geneva: World Health Organization; 2009.
  • [60]Levinson D, Lakoma MD, Petukhova M, Schoenbaum M, Zaslavsky AM, Angermeyer M, Borges G, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Haro JM, Hu C, Karam AN, Kawakami N, Lee S, Lepine J-P, Browne MO, Okoliyski M, Posada-Villa J, Sagar R, Viana MC, Williams DR, Kessler RC: Associations of serious mental illness with earnings: results from the WHO World Mental Health surveys. Br J Psychiatry 2010, 197:114-121.
  • [61]Chatterjee S, Riewpaiboon A, Piyauthakit P, Riewpaiboon W: Cost of informal care for diabetic patients in Thailand. Prim Care Diabetes 2011, 5:109-115.
  • [62]Murray CJ, Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S: Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metrics 2003, 1:1. BioMed Central Full Text
  • [63]Su TT, Sanon M, Flessa S: Assessment of indirect cost of illness in a subsistence farming society by using different valuation methods. Health Policy 2007, 83:353-362.
  • [64]Fernando NA: Understanding and Dealing with High Interest Rates on Microcredit. A Note to Policy Makers in the Asia and Pacific Region. Asian Development Bank: Manila; 2006.
  • [65]World Health Organization: World Health Report 2010 – Health Systems Financing: The Path to Universal Coverage. Geneva: World Health Organization; 2010.
  • [66]Mahal A, Karan A, Engelgau M: The Economic Implications of Non-Communicable Disease for India. Washington, DC: World Bank; 2010. [World Bank/HNP Discussion Paper]
  • [67]Nikolic IA, Stanciole AE, Zaydman M: Chronic Emergency: Why NCDs Matter. Washington, DC: World Bank; 2011. [World Bank/HNP Discussion Paper]
  • [68]He S, Wu F, Webster C, Liu Y: Poverty concentration and determinants in China’s urban low-income neighbourhoods and social groups. Int J Urban Regional 2010, 34:328-349.
  • [69]Babalola JB, Oni A, Atanda A, Oyejola-Oshodi BO: Poverty alleviation in Nigeria: lessons from socioeconomic thoughts of the Yoruba. Int Soc Sci J 2009, 60:403-410.
  • [70]McKay A: Assets and Chronic Poverty: Background Paper. Brighton: Chronic Poverty Research Centre, University of Sussex; 2009.
  • [71]FAO, IFAD, WFP: Reducing Poverty and Hunger: The Critical Role of Financing for Food, Agriculture and Rural Development. Rome: Food and Agriculture Organization of the United Nations; 2002. [International Conference on Financing for Development, Monterrey, Mexico, 18–22 March 2002]
  • [72]United Nations: We the Peoples: The Role of the United Nations in the Twenty-first Century. Report of the Secretary-General. New York: United Nations; 2000. [55th session of the General Assembly – The Millennium Assembly of the United Nations, 6–8 September]
  • [73]Bellows NM, Bellows BW, Warren C: The use of vouchers for reproductive health services in developing countries: systematic review. Trop Med Int Health 2011, 16:84-96.
  • [74]Schmidt J-O, Ensor T, Hossain A, Khan S: Vouchers as demand side financing instruments for health care: a review of the Bangladesh maternal voucher scheme. Health Policy 2010, 96:98-107.
  • [75]Lagarde M, Haines A, Palmer N: The impact of conditional cash transfers on health outcomes and use of health services in low and middle income countries (Review). Cochrane Database Syst Rev 2009, 4:CD008137.
  • [76]UNICEF: Child Poverty: A Role for Cash Transfers in West and Central Africa?. Dakar: UNICEF West and Central Africa Regional Office; 2009. [Briefing Paper]
  • [77]England R: Experience of Contracting with the Private Sector: A Selective Review. London: DFID, Health Systems Resource Centre; 2004.
  • [78]World Health Organization: Non-Communicable Diseases Country Profiles 2011. Geneva: World Health Organization; 2011.
  • [79]World Health Organization: The Global Burden of Disease: 2004 Update. Geneva: World Health Organization; 2008.
  文献评价指标  
  下载次数:4次 浏览次数:8次